LEADER 01705oam  2200457   450 
001 9910705311003321
005 20140902170053.0
035   $a(CKB)5470000002450271
035   $a(OCoLC)879862300
035   $a(EXLCZ)995470000002450271
100   $a20140516d2014      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFDA checkup $edrug development and manufacturing challenges : hearing before the Subcommittee on Energy Policy, Health Care and Entitlements of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Thirteenth Congress, first session, December 12, 2013
210  1$aWashington :$cU.S. Government Printing Office,$d2014.
215   $a1 online resource (iii, 87 pages)
300   $aTitle from title screen (viewed on May 16, 2014).
300   $aPaper version available for sale by the Superintendent of Documents, U.S. Government Printing Office.
300   $a"Serial no. 113-101."
320   $aIncludes bibliographical references.
517   $aFDA checkup 
606   $aDrug development$xGovernment policy$zUnited States
606   $aDrug approval$zUnited States
606   $aDrugs$xTesting$xGovernment policy$zUnited States
608   $aLegislative hearings.$2lcgft
615  0$aDrug development$xGovernment policy
615  0$aDrug approval
615  0$aDrugs$xTesting$xGovernment policy
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bCOO
801  2$bOCLCO
801  2$bGPO
906   $aBOOK
912   $a9910705311003321
996   $aFDA checkup$93517431
997   $aUNINA